FUSD:F:F-Fidelity UCITS SICAV - Fidelity US Quality Income UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 10.34

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.25 (-0.44%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.04 (-0.27%)

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.45 (-0.19%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.41 (+0.38%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.06 (-0.85%)

USD 38.52B
0ZC:F Zscaler Inc

+7.40 (+4.31%)

USD 37.92B

ETFs Containing FUSD:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.41% 80% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.41% 77% C+ 64% D
Trailing 12 Months  
Capital Gain 22.51% 79% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.51% 76% C+ 63% D
Trailing 5 Years  
Capital Gain 66.51% 84% B 78% C+
Dividend Return 12.56% 62% D 28% F
Total Return 79.07% 89% A- 65% D
Average Annual (5 Year Horizon)  
Capital Gain 13.67% 82% B 73% C
Dividend Return 13.67% 80% B- 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.04% 57% F 86% B+
Risk Adjusted Return 113.51% 98% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

What to not like:

There is nothing we particularly dislike